Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas
Corinna Haist, Zoe Poschinski, Arthur Bister, Michèle J. Hoffmann, Camilla M. Grunewald, Alexandra Hamacher, Matthias U. Kassack, Constanze Wiek, Kathrin Scheckenbach, Helmut Hanenberg
Topics & Concepts
CetuximabHead and neck squamous-cell carcinomaMonoclonal antibodyChimeric antigen receptorEpidermal growth factor receptorImmunotherapyCancer researchImmunoglobulin light chainAntibodyCancerHead and neck cancerBiologyMedicineImmunologyInternal medicineCAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design